Displaying 1-10 of 10 result(s).
| Board Name | Posts By King Kurtis | Post Created |
|---|---|---|
| CYDY CytoDyn Inc | I hear you, I just wonder if the Co | 02/05/2025 5:04:49 PM |
| CYDY CytoDyn Inc | His point was if that number is wro  (2) | 02/05/2025 4:43:20 PM |
| CYDY CytoDyn Inc | If the glitch don't fit, we must ac (2) | 02/01/2025 8:59:41 PM |
| CYDY CytoDyn Inc | There is no way you have 7 digit sh (5) | 01/30/2025 2:49:25 PM |
| CYDY CytoDyn Inc | So YOU'RE the one who bought 4 mill | 01/27/2025 2:27:20 PM |
| CYDY CytoDyn Inc | Work in Santa Monica... I stayed at (11) | 01/09/2025 5:27:21 PM |
| CYDY CytoDyn Inc | Very good point! Perhaps they didn' (11) | 10/04/2024 4:35:44 PM |
| CYDY CytoDyn Inc | "Tuesday would be nice!" Can you de (1) | 05/27/2024 5:12:32 PM |
| CYDY CytoDyn Inc | Very nice write-up MGK_2..! Thanks. (1) | 05/26/2024 4:49:48 PM |
| CYDY CytoDyn Inc | "Respectfully disagree. BP is big b (20) | 05/25/2024 8:36:36 PM |
Recent Articles
- California's Innovative AI Curriculum: Preparing Future Leaders
- Concerns Rise Over ETH Treasuries Amid Market Volatility
- Impact of Trump's Tariffs on Developing Nations Explained
- Aaron Fraser's New Guide Fuels Sponsorship Success for Athletes
- Investors' Alert: Join the Flywire Corporation Securities Class Action
- Empowering Attorneys in Miami: SEO for Lawyers Expands Services
- Challenges in US-Mexico Cooperation on Drug Cartels
- Michael Cohen Critiques Trump's Radically New Redistricting Plans
- Dyne Therapeutics Faces Investigation Over Possible Fraud Claims
- Lockheed Martin Investigated for Potential Securities Issues
- Investigation Unfolds: Inspire Medical Systems, Inc. Insights
- Agilon Health Faces Investigation: What Investors Should Know
- Replimune Group, Inc. Securities Lawsuit: Your Rights Explained
- Deep Dive into Mereo BioPharma's Recent Investigations and News
- OpenAI Responds to Demand, Revives GPT-4o After Backlash
- Thumzup Media Corporation Enhances Strategies for Public Offering
- Investigation into Barnes & Noble Education Raises Concerns
- Julia Hartz's Inspiring Journey from TV Executive to CEO
- Pomerantz Law Firm's Review for Charter Communications Investors
- Pomerantz Law Firm Investigates Exelixis, Inc. Investor Claims
- Duolingo Faces Investigation Amid User Engagement Concerns
- Confluent, Inc. Faces Investigation Over Potential Securities Fraud
- Investigation Launched on Tronox Holdings plc Amid Concerns
- Albany International Faces Lawsuit: What Investors Need to Know
- Uncovering Potential Legal Actions Against Praxis Precision Medicines
- Anika Therapeutics Under Investigation as Stock Suffers Loss
- Insight Into NeoGenomics' Ongoing Financial Challenges and Future
- Exploring the Untapped Potential of America's Energy Reserves
- Investigation Launched for Neogen Corporation Investors Amid Concerns
- Novo Nordisk Faces Class Action Over Sales Outlook Adjustments
- Analyzing the Implications of Trump and Putin's Meeting
- Quavo Secures Major Funding to Enhance Fraud Prevention Solutions
- Explore Opportunities in 3D Systems Corporation Securities
- Class Action Filed Against iRobot Corporation: What You Need to Know
- Tesla Faces Class Action as It Expands Autonomous Driving Tech
- Spectrum Pharmaceuticals Faces Class Action Suit Over Misleading Claims
- Class Action Lawsuit Filed Against CTO Realty Growth, Inc.
- Lockheed Martin Investors: Your Chance to Join Class Action Suit
- Important Legal Steps for Neogen Corporation Investors
- Barbara Corcoran Shares Insights on Trump's Sales Tactics
- Luminar Technologies Faces Lawsuit: Investors Take Action
- Navigating the Potential of RxSight Securities Lawsuit
- Stock Market Analysis: Insight into Current Trends and Highlights
- Understanding the Class Action Lawsuit Against RxSight, Inc.
- Faruqi & Faruqi LLP Takes on Altimmune Securities Fraud Case
- PepGen Investors Advised on Class Action Lawsuit Opportunities
- Important Class Action Update for Replimune Investors
- Investor Alert: Rocket Pharmaceuticals Class Action Details
- Faruqi & Faruqi Calls Investors to Act on Sable Offshore Case
- Fluor Corporation: Scrutiny Over Securities Misleading Claims